Azithromycin has been widely evaluated for its efficacy against COVID-19. The study by Timothy S C Hinks and colleagues1 adds value to the current literature, and we would like to share our comments.

With COPD, you can be at risk for serious complications that not only put your health in jeopardy, but also could be fatal. We'll share tips for preventing them.

When It Might Be Used for Sinus Infection There are some circumstances when azithromycin may be used to treat a sinus infection. For example, even though many sinus infections are viral, some people ...

GSK has highlighted approval of Nucala in COPD as one of its top 2025 priorities, adding to its established medicines for the disease, including Trelegy (fluticasone furoate, umeclidinium, and ...

Regeneron’s stock is having its worst day in 14 years after the failure of late-stage trial of its COPD treatment, after analysts had just placed a high probability of a positive result.

COPD — chronic obstructive pulmonary disease — “is a tough disease,” says Colleen Brennan-Martinez, 64, a retired nurse practitioner from New York City whose father, James Brennan, died from COPD in ...

LABAs are central to the management of COPD and the prevention of further exacerbations. [38, 52] Also, new long-acting agents are in development, including LABA and LAMA combination therapies.

EUROPEAN surveillance data from 2022 show a sharp rise in antimicrobial resistance (AMR) in Neisseria gonorrhoeae, raising new concerns about treatment efficacy for this common sexually transmitted ...

Compared with those who tested negative, individuals with COPD who tested positive for COVID-19 had 9% overall higher HCU rates (rate ratio [RR], 1.096; 95% CI, 1.067-1.127), as well as a 13% higher ...

Hospital admissions were reduced by more than 50% in the intervention group (P < .001), highlighting the potential of structured home-based care to break the cycle of frequent exacerbations in ...

For COPD patients, the adage holds true: "the first way to get out of a hole is to quit digging one," said Christopher Mosher, MD, MHS, of Duke University in Durham, North Carolina.

Among patients who have never smoked—“never-smokers”—those with lung cancer (LC) are more likely to have been diagnosed with an inflammatory disease, according to a study published in Nature ...